Sonia A. Perez
Athens, ESYE31 11522, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance.
Journal: Cancers
Published: November 11, 2022
Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design.
Journal: Cancers
Published: September 11, 2020
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer.
Journal: Cancers
Published: May 21, 2020
Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence.
Journal: Breast cancer research and treatment
Published: October 27, 2019
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies.
Journal: Seminars in cancer biology
Published: October 14, 2019
Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 05, 2019
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: May 29, 2019
Prostate cancer: any room left for immunotherapies?
Journal: Immunotherapy
Published: February 08, 2019
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: November 02, 2018
Serum miRNA-based distinct clusters define three groups of breast cancer patients with different clinicopathological and immune characteristics.
Journal: Cancer immunology, immunotherapy : CII
Published: March 08, 2018
Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence - Implications for vaccine trial design.
Journal: Clinical immunology (Orlando, Fla.)
Published: January 01, 2018
Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.
Journal: Journal for immunotherapy of cancer
Published: May 15, 2017
Last Updated: 09/26/2026